Greencross Limited reports and takeover offers will need to be far higher

After a solid set of results that put the company's best foot forward, Greencross Limited (ASX:GXL) is unlikely to be sold without a substantially higher offer.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As I covered yesterday, Greencross Limited (ASX: GXL) management recently rejected a third, increased buyout offer for the company from a consortium led by TPG Capital and The Carlyle Group over the weekend.

After the release of the interim results this morning, it's easy to see why. Greencross knew exactly what its shareholders and would-be buyers were looking for, and it put the information up front.

Here's what you need to know:

  • Group revenue grew 18% to $363m
  • Underlying (excluding significant items) Net Profit After Tax (NPAT) rose 11.5% to $21m
  • Underlying Earnings Per Share (EPS) rose 8.5% to 18.7 cents
  • Gross margins (revenue minus cost of goods sold) expanded by 2.4% to 55.6%
  • Dividends per share rose by 1 cent to 9 cents per share
  • Like-for-Like (LFL, or 'same store') sales grew 5.1%
  • Generated free cash flow of $15.3m
  • Total cash of $54m and total debt of $274m as of 31 December 2015

So What?

A solid performance that no doubt ticked a lot of boxes for shareholders. Rising revenues and profits from growing same-store sales as well as an increasing number of stores speaks for itself. Expanding margins came from the acquisition of new specialty businesses as well as a focus on higher margin veterinary procedures, which were sufficient to offset an increase in sales of lower margin products like food.

Greencross recently refinanced its $350m debt facility ($274m drawn) at lower effective interest rates (5.2%, down from 6%), as well as acquiring an additional $50m 'accordion' facility and an extension in expiry date out to 2020.

On the downside, poor performance in Western Australia continued with same-store sales actually shrinking, confirming that demand for pet care is elastic and vulnerable to an economic downturn. However, it's an open question whether the rest of Australia is likely to suffer a downturn as severe as WA, which has a very mining-centric economy.

The improvement in cash flows came largely as a result of fewer acquisitions, although a fortuitous shift in working capital requirements, from an $11m outflow in the prior corresponding period to a $7m inflow appears to account for much of Greencross' free cash flow over the past six months.

Management attributes this shift to a reduction in trade and other receivables due to improved collections, as well as reductions in in-store inventory.

Now What?

The question of the hour is whether shareholders can expect a higher takeover bid from potential buyers. I have no idea, although today's report confirms management's recent stance on the bids was correct and I continue to believe buyers will have to offer north of $7 per share to get shareholders interested.

Continued strong Australian sales growth despite the commodity downturn confirms that Greencross' model is successful, although shareholders will want to watch for deterioration in the domestic economy. A significant chunk of Greencross' total assets are intangible, which could result in savage write-downs if the company's business suffers. For this reason I would also be wary of over-extension should the aggressive expansion of recent years start up again.

As it stands though, today's results were of very good quality and I continue to believe both that Greencross is undervalued and that it is a good buying opportunity for investors today.

Motley Fool contributor Sean O'Neill owns shares of Greencross Limited. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »